vimarsana.com
Home
Live Updates
Ginkgo Bioworks Reports First Quarter 2023 Financial Results
Ginkgo Bioworks Reports First Quarter 2023 Financial Results
Ginkgo Bioworks Reports First Quarter 2023 Financial Results
Ginkgo added 13 new Cell Programs to the Foundry platform in Q1 2023
Recent acquisition of the adeno-associated virus capsid engineering platform assets of StrideBio is advancing Ginkgo's... | May 10, 2023
Related Keywords
Australia ,
Botswana ,
Rwanda ,
Democratic Republic Of The Congo ,
United Kingdom ,
Saudi Arabia ,
Houston ,
Texas ,
United States ,
Chicago ,
Illinois ,
Qatar ,
Ukraine ,
Boston ,
Massachusetts ,
New York ,
Washington ,
Jason Kelly ,
Ginkgo Bioworks Holdings Inc ,
Instagram ,
Therapeutics Services ,
Twitter ,
Exchange Commission ,
Ginkgo Microbe Services ,
Ginkgo Cell Therapy Services ,
Cell Programs ,
Ginkgo Bioworks Holdings ,
Microbe Services ,
West Sacramento ,
Cell Therapy Services ,
Democratic Republic ,
African Risk ,
Cell Engineering ,
Investor Relations ,
Investor Website ,
Only Dial Ins ,
San Jose ,
Looking Statements ,
Ginkgo Bioworks ,
Bioworks Contacts ,
Bioworks Holdings ,
Consolidated Statements ,
Comprehensive Loss ,
Months Ended March ,
Accounting Standards Codification Topic ,
Cash Flows ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Ginkgo ,
Dded ,
3 ,
Few ,
Fell ,
Programs ,
O ,
The ,
Foundry ,
Platform ,
N ,
1 ,
Cquisition ,
F ,
Virus ,
Capsid ,
Engineering ,
Assets ,
Stridebio ,
Us ,
Dvancing Dna Us37611x1000 ,